Results from the anti-PD-1 treatments showed that the percentage of tumor cells expressing PD-L1 decreased noticeably to ~14% (both in the surgery + anti-PD-1 50 μg and LIT + anti-PD-1 50 μg groups). This evidence concerns the gene CD274 and neoplasm.